advertisement
Nakakura S 13
Showing records 1 to 13 | Display all abstracts from Nakakura S109855 Randomized Multicenter Clinical Trial Comparing 0.1% Brimonidine/0.5% Timolol Versus 1% Dorzolamide/0.5% Timolol as Adjuncts to Prostaglandin Analogues: Aibeta Crossover Study
Inatani M
Advances in Therapy 2023; 40: 4074-4092
109912 Case report: Medical treatment for limbal epithelial stem cell deficiency in patients treated for glaucoma
Nakakura S
Frontiers in medicine 2023; 10: 1161568
109855 Randomized Multicenter Clinical Trial Comparing 0.1% Brimonidine/0.5% Timolol Versus 1% Dorzolamide/0.5% Timolol as Adjuncts to Prostaglandin Analogues: Aibeta Crossover Study
Orii Y
Advances in Therapy 2023; 40: 4074-4092
109912 Case report: Medical treatment for limbal epithelial stem cell deficiency in patients treated for glaucoma
Maruoka S; Chikama T
Frontiers in medicine 2023; 10: 1161568
109855 Randomized Multicenter Clinical Trial Comparing 0.1% Brimonidine/0.5% Timolol Versus 1% Dorzolamide/0.5% Timolol as Adjuncts to Prostaglandin Analogues: Aibeta Crossover Study
Iwasaki K; Arimura S
Advances in Therapy 2023; 40: 4074-4092
109912 Case report: Medical treatment for limbal epithelial stem cell deficiency in patients treated for glaucoma
Nagata Y; Terao E
Frontiers in medicine 2023; 10: 1161568
109855 Randomized Multicenter Clinical Trial Comparing 0.1% Brimonidine/0.5% Timolol Versus 1% Dorzolamide/0.5% Timolol as Adjuncts to Prostaglandin Analogues: Aibeta Crossover Study
Sunagawa H; Shiokawa M
Advances in Therapy 2023; 40: 4074-4092
109912 Case report: Medical treatment for limbal epithelial stem cell deficiency in patients treated for glaucoma
Ueda K
Frontiers in medicine 2023; 10: 1161568
109855 Randomized Multicenter Clinical Trial Comparing 0.1% Brimonidine/0.5% Timolol Versus 1% Dorzolamide/0.5% Timolol as Adjuncts to Prostaglandin Analogues: Aibeta Crossover Study
Inoue K
Advances in Therapy 2023; 40: 4074-4092
109912 Case report: Medical treatment for limbal epithelial stem cell deficiency in patients treated for glaucoma
Dote S
Frontiers in medicine 2023; 10: 1161568
109855 Randomized Multicenter Clinical Trial Comparing 0.1% Brimonidine/0.5% Timolol Versus 1% Dorzolamide/0.5% Timolol as Adjuncts to Prostaglandin Analogues: Aibeta Crossover Study
Sakono T
Advances in Therapy 2023; 40: 4074-4092
109912 Case report: Medical treatment for limbal epithelial stem cell deficiency in patients treated for glaucoma
Oogi S
Frontiers in medicine 2023; 10: 1161568
109855 Randomized Multicenter Clinical Trial Comparing 0.1% Brimonidine/0.5% Timolol Versus 1% Dorzolamide/0.5% Timolol as Adjuncts to Prostaglandin Analogues: Aibeta Crossover Study
Sakono T; Kuwamura R; Yoshida A; Oi J; Kuwayama Y; Kano K; Kido N; Matsuyama A; Ozaki M; Abe H; Inoue C; Nakagawa S; Musashi K; Kanamori A; Lee J; Otani S; Aoki R; Tanabe H; Nakakura S; Suzuki K; Sagara T; Saito Y; Sameshima M; Urahashi M; Watanabe-Kitamura F; Inoue T; Kagaya F; Murai Y; Mori S; Ueda K; Kurimoto T; Yamada-Nakanishi Y; Yamada-Nakanishi Y; Nakamura M; Yamashita T; Ishiyama S; Manabe S; Takaki K; Hayashi K; Ishida A; Tsutsui A; Tsutsui A; Manabe K; Tanito M
Advances in Therapy 2023; 40: 4074-4092
